Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD)
Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD)
$6.55 USD
0.12 (-1.80%)
Updated Jun 25 8:00pm
Add GLMD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
GLMD Daily Price Range
GLMD 52-Week Price Range
GLMD News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Tesla (TSLA) shares are down after Electrek says it may miss its 2Q delivery target
Tyson Foods (TSN) shares dive on report that it’s being investigated for price fixing
Shares of marijuana firm Hexo (HEXO) tank following downgrade from Oppenheimer
Why UBS says recent strength in Hostess (TWNK) shares have a lot more upside
Why investors shouldn’t be in a hurry to buy Cronos Group (CRON) shares
View All Top StoriesGalmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) Company Bio
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. The company was founded in 2000 and is based in Tel Aviv, Israel.
GLMD Stock Chart More Charts
GLMD Price/Volume Stats
| Current price | $6.55 |
| Prev. close | $6.67 |
| Day low | $6.36 |
| Day high | $6.65 |
| 50-day MA | $6.91 |
| 200-day MA | $8.72 |
| 52-week high | $15.98 |
| 52-week low | $5.48 |
| Volume | 41,400 |
| Avg. volume | 95,983 |
| Dividend yield | N/A |
| Market Cap | 137.67M |
GLMD Returns
| 1-mo | 2.02% |
| 3-mo | -19.14% |
| 6-mo | -9.78% |
| 1-year | -50.00% |
| 3-year | 37.32% |
| 5-year | -33.77% |
| YTD | -4.10% |
| 2018 | -25.36% |
| 2017 | 160.68% |
| 2016 | -53.88% |
| 2015 | 31.21% |
| 2014 | N/A |
Loading social stream, please wait...